慢性阻塞性肺疾病(COPD)是一个全球性的公共卫生问题,常由气道或者肺泡的异常所导致。COPD可累及多个系统,其中骨骼肌肉系统就是之一,可导致肌少症,肌少症又可加速疾病的进程,增加患者的住院率及死亡率。因此,本文就慢性阻塞性肺疾病与肌少症之间的相关性展开综述。Chronic obstructive pulmonary disease (COPD) is a global public health problem, often caused by abnormalities in the airway or alveoli. COPD can involve multiple systems, of which the skeletal muscle system is one, can lead to sarcopenia, and sarcopenia can accelerate the process of the disease, increase the rate of hospitalization and mortality of patients. Therefore, this article reviews the correlation between chronic obstructive pulmonary disease and sarcopenia.
耐药肺结核是指结核病患者感染了耐药的结核分枝杆菌,使得结核病的治疗效果降低,病情加重,增加治疗难度,增加治疗费用,导致病情反复发作,尤其是耐多药肺结核的传染周期长,治疗难度大,治疗费用高,治愈率低,死亡率高。分析耐药肺结核的影响因素,对患者实施个体化治疗至关重要。耐药结核病存在多种治疗策略,化学治疗仍然被视为对抗耐药结核病最为关键的方法。本文将概述国内外耐药结核病的流行状况及其治疗方法,旨在为临床优化与提升耐药结核病的治疗效果提供参考依据。Drug-resistant tuberculosis refers to when tuberculosis patients are infected with drug-resistant Mycobacterium tuberculosis, which reduces the treatment effect of tuberculosis, aggravates the condition, increases the difficulty of treatment, increases the cost of treatment, and leads to repeated attacks of the disease, especially multidrug-resistant tuberculosis, which has a long infection cycle, difficult treatment, high treatment cost, low cure rate and high mortality. It is important to analyze the influencing factors of drug-resistant tuberculosis to implement individualized treatment for patients. There are multiple treatment strategies for drug-resistant TB, and chemotherapy is still considered the most critical approach in the fight against drug-resistant TB. This article will summarize the prevalence and treatment methods of drug-resistant tuberculosis at home and abroad, aiming to provide reference for clinical optimization and improvement of the therapeutic effect of drug-resistant tuberculosis.
